Ph.D. Gail K. Naughton - 03 Nov 2025 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Director
Signature
/s/ Gail K. Naughton, Ph.D.
Issuer symbol
TXMD
Transactions as of
03 Nov 2025
Net transactions value
$0
Form type
4
Filing time
05 Nov 2025, 16:17:44 UTC
Previous filing
20 Feb 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Naughton Gail K Director 951 YAMATO ROAD, SUITE 220, BOCA RATON /s/ Gail K. Naughton, Ph.D. 05 Nov 2025 0001297506

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +8,500 $0.000000 8,500 03 Nov 2025 Common Stock 8,500 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSUs will vest on November 3, 2028.